Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Preclinical CRO Treatment Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Preclinical CRO Treatment Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Bioanalysis and DMPK Studies
      • 1.3.3 Toxicology Testing
      • 1.3.4 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Preclinical CRO Treatment Market Share by Application (2019-2025)
      • 1.4.2 Biopharmaceutical Companies
      • 1.4.3 Government and Academic Institutes
      • 1.4.4 Medical Device Companies
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Preclinical CRO Treatment Market Size
      • 2.1.1 Global Preclinical CRO Treatment Revenue 2014-2025
      • 2.1.2 Global Preclinical CRO Treatment Sales 2014-2025
    • 2.2 Preclinical CRO Treatment Growth Rate by Regions
      • 2.2.1 Global Preclinical CRO Treatment Sales by Regions 2014-2019
      • 2.2.2 Global Preclinical CRO Treatment Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Preclinical CRO Treatment Sales by Manufacturers
      • 3.1.1 Preclinical CRO Treatment Sales by Manufacturers 2014-2019
      • 3.1.2 Preclinical CRO Treatment Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Preclinical CRO Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Preclinical CRO Treatment Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Preclinical CRO Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.3 Preclinical CRO Treatment Price by Manufacturers
    • 3.4 Key Manufacturers Preclinical CRO Treatment Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Preclinical CRO Treatment Market
    • 3.6 Key Manufacturers Preclinical CRO Treatment Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Bioanalysis and DMPK Studies Sales and Revenue (2014-2019)
      • 4.1.2 Toxicology Testing Sales and Revenue (2014-2019)
      • 4.1.3 Others Sales and Revenue (2014-2019)
    • 4.2 Global Preclinical CRO Treatment Sales Market Share by Type
    • 4.3 Global Preclinical CRO Treatment Revenue Market Share by Type
    • 4.4 Preclinical CRO Treatment Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Preclinical CRO Treatment Sales by Application

    6 United States

    • 6.1 United States Preclinical CRO Treatment Breakdown Data by Company
    • 6.2 United States Preclinical CRO Treatment Breakdown Data by Type
    • 6.3 United States Preclinical CRO Treatment Breakdown Data by Application

    7 European Union

    • 7.1 European Union Preclinical CRO Treatment Breakdown Data by Company
    • 7.2 European Union Preclinical CRO Treatment Breakdown Data by Type
    • 7.3 European Union Preclinical CRO Treatment Breakdown Data by Application

    8 China

    • 8.1 China Preclinical CRO Treatment Breakdown Data by Company
    • 8.2 China Preclinical CRO Treatment Breakdown Data by Type
    • 8.3 China Preclinical CRO Treatment Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Preclinical CRO Treatment Breakdown Data by Company
    • 9.2 Rest of World Preclinical CRO Treatment Breakdown Data by Type
    • 9.3 Rest of World Preclinical CRO Treatment Breakdown Data by Application
    • 9.4 Rest of World Preclinical CRO Treatment Breakdown Data by Countries
      • 9.4.1 Rest of World Preclinical CRO Treatment Sales by Countries
      • 9.4.2 Rest of World Preclinical CRO Treatment Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Charles River Laboratories
      • 10.1.1 Charles River Laboratories Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Preclinical CRO Treatment
      • 10.1.4 Preclinical CRO Treatment Product Introduction
      • 10.1.5 Charles River Laboratories Recent Development
    • 10.2 Laboratory Corporation of America
      • 10.2.1 Laboratory Corporation of America Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Preclinical CRO Treatment
      • 10.2.4 Preclinical CRO Treatment Product Introduction
      • 10.2.5 Laboratory Corporation of America Recent Development
    • 10.3 Envigo
      • 10.3.1 Envigo Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Preclinical CRO Treatment
      • 10.3.4 Preclinical CRO Treatment Product Introduction
      • 10.3.5 Envigo Recent Development
    • 10.4 Eurofins Scientific
      • 10.4.1 Eurofins Scientific Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Preclinical CRO Treatment
      • 10.4.4 Preclinical CRO Treatment Product Introduction
      • 10.4.5 Eurofins Scientific Recent Development
    • 10.5 PRA Health Science
      • 10.5.1 PRA Health Science Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Preclinical CRO Treatment
      • 10.5.4 Preclinical CRO Treatment Product Introduction
      • 10.5.5 PRA Health Science Recent Development
    • 10.6 Wuxi AppTec
      • 10.6.1 Wuxi AppTec Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Preclinical CRO Treatment
      • 10.6.4 Preclinical CRO Treatment Product Introduction
      • 10.6.5 Wuxi AppTec Recent Development
    • 10.7 Medpace
      • 10.7.1 Medpace Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Preclinical CRO Treatment
      • 10.7.4 Preclinical CRO Treatment Product Introduction
      • 10.7.5 Medpace Recent Development
    • 10.8 Pharmaceutical Product Development
      • 10.8.1 Pharmaceutical Product Development Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Preclinical CRO Treatment
      • 10.8.4 Preclinical CRO Treatment Product Introduction
      • 10.8.5 Pharmaceutical Product Development Recent Development
    • 10.9 Paraxel
      • 10.9.1 Paraxel Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Preclinical CRO Treatment
      • 10.9.4 Preclinical CRO Treatment Product Introduction
      • 10.9.5 Paraxel Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Preclinical CRO Treatment Sales Channels
      • 11.2.2 Preclinical CRO Treatment Distributors
    • 11.3 Preclinical CRO Treatment Customers

    12 Market Forecast

    • 12.1 Global Preclinical CRO Treatment Sales and Revenue Forecast 2019-2025
    • 12.2 Global Preclinical CRO Treatment Sales Forecast by Type
    • 12.3 Global Preclinical CRO Treatment Sales Forecast by Application
    • 12.4 Preclinical CRO Treatment Forecast by Regions
      • 12.4.1 Global Preclinical CRO Treatment Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Preclinical CRO Treatment Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      A preclinical CRO treatment is likely to offer the knowledge, experience, and skill needed to take a pharmaceutical medical device or product from the drawing board to distribution. The preclinical contract research organizations (CRO) sector has witnessed a period of tremendous development in the past, profiting from quickly growing (R&D) spending. Several pharmaceutical companies have lost revenue owing to growing patent expirations thus encouraging several manufacturers to outsource factors of the drug manufacturing method to CROs to decrease costs. Due to this, CROs are witnessing significant development.
      In 2019, the market size of Preclinical CRO Treatment is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Preclinical CRO Treatment.

      This report studies the global market size of Preclinical CRO Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Preclinical CRO Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Charles River Laboratories
      Laboratory Corporation of America
      Envigo
      Eurofins Scientific
      PRA Health Science
      Wuxi AppTec
      Medpace
      Pharmaceutical Product Development
      Paraxel

      Market Segment by Product Type
      Bioanalysis and DMPK Studies
      Toxicology Testing
      Others

      Market Segment by Application
      Biopharmaceutical Companies
      Government and Academic Institutes
      Medical Device Companies

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Preclinical CRO Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Preclinical CRO Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Preclinical CRO Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now